# Step-up to Medium Strength Triple Therapy vs High Strength ICS/LABA in Adult Asthmatics Uncontrolled on Medium Strength ICS/LABA

> **NCT05018598** · PHASE4 · TERMINATED · sponsor: **Chiesi Farmaceutici S.p.A.** · enrollment: 320 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** Administration via pressurized metered dose inhaler (pMDI)
- **DRUG:** Administration via pressurized metered dose inhaler (pMDI)

## Key facts

- **NCT ID:** NCT05018598
- **Lead sponsor:** Chiesi Farmaceutici S.p.A.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2022-02-25
- **Primary completion:** 2024-04-16
- **Final completion:** 2024-04-16
- **Target enrollment:** 320 (ACTUAL)
- **Why stopped:** The study was prematurely stopped due to extensive challenges in patient recruitment. The Sponsor issued a notification of early study termination to all investigational sites and all external stakeholders.
- **Last updated:** 2024-11-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05018598

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05018598, "Step-up to Medium Strength Triple Therapy vs High Strength ICS/LABA in Adult Asthmatics Uncontrolled on Medium Strength ICS/LABA". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT05018598. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*